alexa Alexander Panossian | Swedish Herbal Institute
ISSN : 2153-2435

Pharmaceutica Analytica Acta
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Alexander Panossian

Alexander Panossian Alexander Panossian
Professor
Swedish Herbal Institute
Sweden
Tel: +46-430-23723
Fax: +46-430-23098
Biography

Roderick Slavcev specializes in gene therapy and biochemistry of nucleic acids with experience in both academic and industrial settings. Prior to gathering valuable marketing and clinical experience as a medical liaison for the pharmaceutical industry he completed his post-doctoral fellowship at the Department of Medical Genetics and Microbiology at the University of Toronto in the area of bacteriophage P1 plasmid partition and chromosomal segregation. His current research group comprises Mediphage Bioceuticals (MB) and encompasses pharmaceutics, cell biology, genetics, molecular biology, virology and technology transfer within the ultimate aim of bringing new treatments to the global environment, especially less developed countries. MB research projects focus on bacteriophage-based biotechnology and include the use of coliphages and phage-encoded genes and genetic elements to design and construct vectors for the development of novel vaccines, biopharmaceuticals and gene therapy systems, and the identification and application of novel phage genomic anti-bacterial genes to treat and dispose of the clinical culprits of global bacterial infection.
Roderick Slavcev is an Assistant Professor, Pharmaceutical Sciences at the University of Waterloo, School of Pharmacy and holds the Shopper’s Drug Mart Professor of Business and Entrepreneurship Chair. Holding an MBA specialized in biopharma management and commercialization, Roderick currently directs and delivers the School of Pharmacys novel business curriculum initiative. He also created and was instrumental in designing the first Medical Microbiology Laboratory to be offered by a Canadian Pharmacy curriculum.

Research Interest

His current research group comprises Mediphage Bioceuticals  and encompasses pharmaceutics, cell biology, genetics, molecular biology, virology and technology transfer within the ultimate aim of bringing new treatments to the global environment, especially less developed countries. MB research projects focus on bacteriophage-based biotechnology and include the use of coliphages and phage-encoded genes and genetic elements to design and construct vectors for the development of novel vaccines, biopharmaceuticals and gene therapy systems, and the identification and application of novel phage genomic anti-bacterial genes to treat and dispose of the clinical culprits of global bacterial infection.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords